Yale Global Tic Severity Scale (YGTSS)

[1]  E. Storch,et al.  Defining treatment response in pediatric tic disorders: a signal detection analysis of the Yale Global Tic Severity Scale. , 2011, Journal of child and adolescent psychopharmacology.

[2]  A. Hartmann,et al.  European clinical guidelines for Tourette Syndrome and other tic disorders. Part I: assessment , 2011, European Child & Adolescent Psychiatry.

[3]  Golda S. Ginsburg,et al.  Behavior therapy for children with Tourette disorder: a randomized controlled trial. , 2010, JAMA.

[4]  F. Rivas-Ruiz,et al.  Adaptación al español y validez diagnóstica de la Yale Global Tics Severity Scale , 2008 .

[5]  C. Li,et al.  Behavioral and emotional problems in adolescents with Tourette syndrome. , 2008, Chang Gung medical journal.

[6]  E. Storch,et al.  Factor-analytic study of the Yale Global Tic Severity Scale , 2007, Psychiatry Research.

[7]  S. Rauch,et al.  Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. , 2006, Behaviour research and therapy.

[8]  M. Robertson,et al.  Depressive symptomatology in young people with Gilles de la Tourette Syndrome-- a comparison of self-report scales. , 2006, Journal of affective disorders.

[9]  Po-Zi Liu,et al.  Comorbid Behavioural Problems in Tourette's Syndrome are Positively Correlated with the Severity of Tic Symptoms , 2006, The Australian and New Zealand journal of psychiatry.

[10]  Jonathan W. Roberti,et al.  Reliability and validity of the Yale Global Tic Severity Scale. , 2005, Psychological assessment.

[11]  O. Bruni,et al.  Disturbi da tic e disturbi dell'arousal. Valutazione clinica di 49 bambini e adolescenti. , 2004 .

[12]  D. Gilbert,et al.  Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[13]  L. Baer,et al.  Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. , 2003, The American journal of psychiatry.

[14]  H. Emrich,et al.  Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. , 2003, The Journal of clinical psychiatry.

[15]  B. Peterson,et al.  A placebo-controlled trial of risperidone in Tourette syndrome , 2003, Neurology.

[16]  D. Gilbert,et al.  Tic reduction with pergolide in a randomized controlled trial in children , 2003, Neurology.

[17]  S. Kuperman,et al.  Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[18]  D. Gilbert,et al.  Tourette’s syndrome improvement with pergolide in a randomized, double-blind, crossover trial , 2000, Neurology.

[19]  H. Singer,et al.  The validity of instruments measuring tic severity in Tourette's syndrome. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[20]  D. Cohen,et al.  The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  A. Shapiro,et al.  Controlled study of pimozide vs. placebo in Tourette's syndrome. , 1984, Journal of the American Academy of Child Psychiatry.

[22]  D. Cohen,et al.  A new instrument for clinical studies of Tourette's syndrome. , 1984, Journal of the American Academy of Child Psychiatry.

[23]  C. Tanner,et al.  Cholinergic mechanisms in Tourette syndrome , 1982, Neurology.

[24]  P. Stefanoff,et al.  [Validity and reliability of Polish adaptation of Yale Global Tic Severity Scale (YGTSS) in a study of Warsaw schoolchildren aged 12-15]. , 2005, Przeglad epidemiologiczny.